Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials

From:
Department for International Development
Published
1 January 2009
Document Type:
Evaluation Report
Theme:
Health
Authors:
Cox, J., Stevens, G., Tarragona-Fiol, T., Hural, J., Cleland, N., Denny, T., Needham, L., Ozaki, D., Rodriguez-Chavez, I.R., Sarzotti-Kelsoe, M., Simkins, A., Stiles, T.

Abstract

This paper addresses for the first time an attempt to harmonize Good Clinical Laboratory Practice (GCLP) approaches into a single set of recommendations for optimal operations and management that can be followed by clinical laboratories, not only in the HIV field, but also possibly in other science and medical fields.

Citation

Cleland, N.; Cox, J.; Denny, T.; Hural, J.; Needham, L.; Ozaki, D.; Rodriguez-Chavez, I.R.; Sarzotti-Kelsoe, M.; Simkins, A.; Stevens, G.; Stiles, T.; Tarragona-Fiol, T. Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials. PLoS Medicine (2009) 6 (5) e1000067. [DOI: 10.1371/journal.pmed.1000067]

Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials

Updates to this page

Published 1 January 2009
Contents